As might be expected, higher IL-17 serum level was also correlated with longer survival, which is consistent with previous demonstration that IL-17 and IL-6 and IL-1β, which promote human Th17 cell differentiation, are members of clusters of cytokines that correlate with better prognosis in CLL [27]. The gene discussed is IL6; the disease is B-cell chronic lymphocytic leukemia.